EUVIMEDEUVIMED entdecken
Crossref

Trends in CRKP Prevalence and Risk Factors for CRKP Hospital-Acquired Infections in Pediatric Patients Pre-, During-, and Post-COVID-19 Pandemic

Chengjiao Luo, Qian Chen

Microbial Drug Resistance · 2025

DOI: 10.1089/mdr.2024.0136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Drug Resistance, 2025. Verfasst von Chengjiao Luo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, People's Republic of China. Hauptthemen laut MEDLINE: COVID-19, Cross Infection, Klebsiella pneumoniae, Klebsiella Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to delineate the epidemiological trends of carbapenem-resistant Klebsiella pneumoniae (CRKP) in pediatric patients before, during, and after coronavirus disease 2019 (COVID-19) pandemic and to assess the risk factors of CRKP hospital-acquired infections (CRKP-HAIs) across these three periods. We retrospectively collected the clinical data of pediatric patients diagnosed with K. pneumoniae infection at the Children’s Hospital of Nanjing Medical University from January 2018 to March 2024. Carbapenemase-related genes were detected by PCR, and statistical analysis was conducted using SPSS 25.0. The current study found that modifications in the COVID-19 pandemic prevention and control measures and antibiotic therapies impact the epidemiological trends and antimicrobial resistance of CRKP. Binary logistic regression analyses revealed various independent risk factors for CRKP-HAIs before, during, and after the COVID-19 pandemic. Healthcare institutions must intensify surveillance for HAIs, continuously monitor and avoid risk factors for CRKP-HAIs, and formulate targeted preventive and control measures to effectively reduce the incidence and spread of these infections. Further, consistent surveillance of CRKP strains coproducing carbapenemase genes is crucial for mitigating the potential health risks in pediatric patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Cross InfectionKlebsiella pneumoniaeKlebsiella InfectionsHumansRisk FactorsChildFemaleMaleRetrospective StudiesChild, PreschoolPrevalenceInfantSARS-CoV-2Anti-Bacterial AgentsAdolescentChinabeta-LactamasesBacterial ProteinsCarbapenemsHospitals, Pediatric

Stichwörter der Autor:innen

COVID-19carbapenem-resistant Klebsiella pneumoniaecarbapenemase geneshospital-acquired infectionsrisk factors

Substanzen

Anti-Bacterial Agentscarbapenemasebeta-LactamasesBacterial ProteinsCarbapenems

Autor:innen und Institutionen

  • Institute of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, People's Republic of China.

Zitieren

APA

Luo, C., & Chen, Q. (2025). Trends in CRKP Prevalence and Risk Factors for CRKP Hospital-Acquired Infections in Pediatric Patients Pre-, During-, and Post-COVID-19 Pandemic. Microbial Drug Resistance. https://doi.org/10.1089/mdr.2024.0136

Vancouver

Luo C, Chen Q. Trends in CRKP Prevalence and Risk Factors for CRKP Hospital-Acquired Infections in Pediatric Patients Pre-, During-, and Post-COVID-19 Pandemic. Microbial Drug Resistance. 2025. doi:10.1089/mdr.2024.0136

BibTeX
@article{Luo2025,
  author = {Luo, Chengjiao and Chen, Qian},
  title = {Trends in CRKP Prevalence and Risk Factors for CRKP Hospital-Acquired Infections in Pediatric Patients Pre-, During-, and Post-COVID-19 Pandemic},
  journal = {Microbial Drug Resistance},
  year = {2025},
  doi = {10.1089/mdr.2024.0136}
}
Kostenlos starten →